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Nodular lymphocyte-predominant Hodgkin lymphoma is an uncommon variant of Hodgkin lymphoma. Progressive trans-
formation of germinal centers has been associated with and can develop prior to, concurrent with, or after the diagnosis of
nodular lymphocyte-predominant Hodgkin lymphoma. We present a patient with a history of progressive transformation of
germinal centers of the right parotid who presented 4 years later with ipsilateral parotid mass and cervical adenopathy. Knowledge
of her previous diagnosis raised our concern for lymphoma, in4uenced our surgical management, and spared the patient
additional surgery with risk of facial nerve injury inherent in revision parotidectomy.
1. Introduction
Masses of the parotid gland warrant thorough investigation,
as 15–32% of parotid gland masses are found to be ma-
lignant [1]. *e course of malignant parotid gland tumors
or other salivary gland tumors is highly variable, but they
have the potential to be aggressive and result in high levels
of morbidity and mortality. Painless swellings of the pa-
rotid gland, especially those involving the facial nerve,
necessitate pathologic examination with either >ne-needle
aspiration (FNA) or ultrasound-guided core needle biopsy.
FNA, in particular, has been found to be highly speci>c in
determining benign versus malignant parotid gland lesions
[2] and is strongly recommended when the mass could
possibly represent mimickers such as TB, lymphoma, or
enlarged lymph nodes [1].
Alternatively, progressive transformation of germinal
centers (PTGC) typically presents as an asymptomatic
enlarged lymph node of the head and neck [2]. First re-
ported by Lennert and Mu¨ller-Hermelink, PTGC is a be-
nign condition that can be mistaken for malignant processes
such as nodular lymphocyte-predominantHodgkin lymphoma
(NLPHL) and follicular lymphoma [3]. *e name itself
somewhat describes the entity; the germinal center ex-
pands as mantle zone lymphocytes in>ltrate the germinal
center and blur the margin between the mantle zone and
germinal center [2, 4]. Although the pathogenesis of PTGC
is unclear and likely multifactorial, it is believed to be a
state of follicular hyperplasia following reactive stimuli
[5, 6]. PTGC and nodular lymphocyte-predominant
Hodgkin lymphoma (NLPHL) are often found concur-
rently, or with one entity preceding the other. While PTGC
may precede NLPHL, some studies have shown that pa-
tients with PTGC did not show an increased risk for
developing NLPHL, making it uncertain whether the
clonal population of cells comprising NLPHL arises from
PTGC directly [2, 6].
PTGC presents most often in males with a 3 : 1 male to
female ratio and generally presents as painless, persistent
lymphadenopathy [7]. Cervical chain lymph nodes are
most frequently aGected by PTGC, with nearly 50% of
cases, followed by inguinal (25%) and axillary (22%) [1].
Approximately 3.5–10% of patients presenting with pain-
less, persistent lymphadenopathy are diagnosed with
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PTGC [8]. In prior reports, anywhere between 16 and 35%
of PTGC are associated with NLPHL [7, 9, 10].
We present a case of a 39-year-old female patient in
which the knowledge of prior diagnosis of PTGC in4uenced
workup and management when she presented with re-
current parotid mass and ipsilateral lymphadenopathy.
2. Case Report
A 39-year-old female presented to the clinic with right neck
lymphadenopathy and an apparent ipsilateral parotid mass.
Her previous history was signi>cant for ipsilateral super>cial
parotidectomy and neck dissection performed at another in-
stitution. Per the patient, the pathology report from her
parotidectomy showed no lymphoma or othermalignancy, but
she did mention that she was sent to an oncologist after
surgery. After a four-year symptom-free interval, she presented
to us with recurrent right parotid mass, neck lymphadenop-
athy, fatigue, andweight loss. Facial nerve was intact bilaterally.
Given the recurrent nature, presence of lymphadenopa-
thy, and the patient’s age, suspicion of malignancy was high.
Multiple >ne-needle aspiration biopsies of the cervical lymph
nodes and parotid mass failed to establish diagnosis. When
pathology was obtained from her previous surgery, the report
described PTGC. After review of the pathology from the
previous procedure, the decision was made to proceed with
excisional biopsy of level II cervical lymph node, sparing the
previously operated parotid space with inherent risk of facial
nerve injury in revision parotidectomy. Pathology revealed
NLPHL in a portion of the node, adjacent to areas of PTGC.
*e patient had an uncomplicated postoperative re-
covery without facial nerve injury or other morbidities.
Postoperative PET/CT showed hypermetabolic lymphade-
nopathy of the right neck, parotid, and right inguinal areas.
She was treated with chemotherapy with good response to
treatment.
3. Pathology Discussion
It is well known that progressive transformation of germinal
centers can mimic nodular lymphocyte-predominant Hodgkin
lymphoma both clinically and histologically [3]. While PTGC
may be a precursor of NLPHL, many patients with PTGC do
not develop NLPHL later in life [11]. Of note, PTGC may be
present in the same lymph node as NLPHL; thus, careful
sampling is required to exclude malignancy in lymph nodes
involved by PTGC [12]. Progressively transformed follicles are
similar to NLPHL nodules in that they are composed of
nonneoplastic small mantle B cells. However, interspersed
hyperplastic follicles are typically present, which is not usual in
NLPHL [3]. In addition, the nodules do not contain the
neoplastic lymphocyte-predominant (LP) cells seen in NLPHL.
*ese LP cells are larger atypical lymphocytes with lobulated
nuclei resembling kernels of popped corn also referred to as
popcorn cells [13]. By immunohistochemical staining, the LP
cells express CD20 and CD45 while being negative for CD15
(a) (b)
(c)
(d) (e)
Figure 1: (a) Low-power H&E staining showing prominent nodules in the background of reactive lymphoid tissue. (b) Interspersed large
“popcorn” lymphocyte-predominant cells. (c) Large popcorn cells are positive for CD20. (d) CD3-positive T cells form rosettes around
the large popcorn cells. (e) CD21 staining showing expanded follicular dendritic network in the large nodule.
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and CD30. In addition, PD-1-positive T cells form rosettes
around LP cells in NLPHL [13].
4. Discussion
A parotid mass with lymphadenopathy in an adult patient
necessitates evaluation.While FNA is commonly employed in
the workup of salivary lesions or lymphadenopathy, it is often
nondiagnostic when dealing with hematogenous malignan-
cies, with core biopsy or excisional biopsy often needed to
provide adequate sample for analysis of node architecture and
diagnosis. *is particular patient presented with worrisome
progressive enlargement, weight loss, and concern for ma-
lignancy. At the initial clinic encounter when pathology from
the prior surgery was unavailable, the lymphadenopathy
prompted concern for carcinoma ex pleomorphic (given her
previous parotidectomy), metastatic squamous cell carci-
noma, mucoepidermoid carcinoma, or some other primary
salivary malignancies. After previous pathology was obtained,
the noted association between PTGC and NLPHL was
considered when FNA as a diagnostic modality failed. *is
in4uenced surgical decision-making and led us to undertake
excisional biopsy of a cervical node rather than parotidec-
tomy. Based on frozen section which suggested hematologic
malignancy was most likely, this spared the patient an ex-
tensive revision parotidectomy and the associated morbidity
of such a surgery.
In a thorough English language literature search, the
percentage of cases of progressive transformation of germinal
centers associated with nodular lymphocyte-predominant
Hodgkin lymphoma was 25.1%, as shown in Figure 1. *e
diagnosis of NLPHL could precede, antecede, or appear
concurrently with a diagnosis of PTGC. Prior reports found
the association to be between 16 and 35% [7, 11]. A PTGC
diagnosis prior to a diagnosis of NLPHL, as in the case of our
patient, is rare. In our literature review, a total of 9 reported
cases out of 275 (3.27%) were found to have PTGC preceding
diagnosis of NLPHL. However, the association overall is
suQcient to consider following patients with either PTGC or
NLPHL for development of the alternative disease. Addi-
tionally, as the rate of concurrent PTGC and NLPHL has the
strongest association, it is important to be certain of a single
diagnosis when either is discovered. A diagnosis of NLPHL
succeeding PTGC may appear anywhere from less than one
year to 13 years after the diagnosis of PTGC, and the fear of
diagnosis may lead to multiple repeat biopsies [14]. Although
our patient’s NLPHL was found in the same location as her
prior PTGC, NLPHL may be found in separate lymph nodes,
most commonly of the cervical chain [7]. *ere is no con-
sensus at this point regarding the appropriate follow-up in-
terval or imaging for PTGC. Further study should be
considered to evaluate the proper interval and duration of
follow-up for patients with PTGC (Table 1).
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